Scientist studying aging reversal and gut-brain axis connections in a modern biomedical laboratory
| | |

The Gut Molecule That Sabotages Your Metabolism: Inside Imidazole Propionate and the 2025 Atherosclerosis Breakthrough

A gut bacterial metabolite called imidazole propionate has gone from obscure molecule to validated driver of insulin resistance, type 2 diabetes, heart failure, and atherosclerosis. Inside the University of Gothenburg…

The Daily Rounds: Longevity & Health Care Brief | June 10, 2026
|

The Daily Rounds: Longevity & Health Care Brief | June 10, 2026

🧠 Ultra-Processed Foods Steal Your Focus: Even among healthy eaters, each 10% increase in ultra-processed food intake measurably impairs attention in a 2,100-person study. 🔬 A Single Gene Proves Evolution's Aging Trade-Off: Hebrew University's CRISPR study of vgll3 provides the first vertebrate experimental proof that fast early growth directly accelerates aging and cancer risk. ❤️ Finerenone Expands Protection to Millions More Patients: Three ERA Congress 2026 trials show the drug delivers significant heart and kidney protection to non-diabetic CKD patients with previously limited options. 🧠 ETH Zurich Discovers New Alzheimer's Mechanism: Compound 10 blocks a newly identified GRK2 aggregation process that damages mitochondria and promotes amyloid formation in brain cells. 🥗 Vegetable Nitrates Deliver Targeted Heart Protection: Source matters; vegetable-derived nitrates cut cardiovascular disease risk 15% in 54,000 adults while processed meat nitrates show no comparable benefit.

Phosphatidylcholine mitochondria aging research in longevity laboratory | Healthcare Discovery
| | |

Five Years of Proof: The Personalized mRNA Cancer Vaccine That Halved Melanoma Recurrence

Five-year data from the KEYNOTE-942 trial, presented at ASCO 2026, show that intismeran autogene plus Keytruda sustains a 49% reduction in melanoma recurrence risk and drives overall survival to 92.2%…

The Daily Rounds: Longevity & Health Care Brief | June 9, 2026
|

The Daily Rounds: Longevity & Health Care Brief | June 9, 2026

🤖 Pancreatic Cancer Gets Its Biggest Breakthrough in a Decade: Daraxonrasib nearly doubles median survival versus chemotherapy, earning a standing ovation at ASCO 2026 and advancing toward FDA submission. 🦠 Gut Bacteria Talk to Your Immune System in a Newly Discovered Molecular Language: A Helmholtz Munich team maps over 1,000 direct protein interactions between common gut bacteria and human cells, fundamentally reframing how the microbiome shapes immunity. ❤️ Night Owl Cardiac Risk Is Mostly Behavioral, Not Biological: AHA research shows the elevated heart disease risk for evening types is largely explained by modifiable lifestyle factors, making it genuinely actionable. 💪 Grip Strength Is a Mortality Predictor for Older Women, Period: The largest study of its kind confirms muscle strength protects women over 60 from early death regardless of how much aerobic exercise they do. 🥗 GLP-1 Success Depends on What You Keep, Not Just What You Lose: A new clinical framework urges practitioners to prioritize muscle preservation alongside weight loss in GLP-1 therapy to protect long-term function and metabolic health.

Scientist studying aging reversal and gut-brain axis connections in a modern biomedical laboratory
| | |

The Brain Has Its Own Immune System. Rejuvenating It May Be the Next Frontier in Cognitive Aging

A deep dive into neuroinflammageing and the 2025 to 2026 research showing the brain’s resident immune cells, the microglia, drive cognitive aging, and how scientists at Cedars-Sinai, UC Irvine, and…

Healthcare Discovery precision medicine genomics preventive health 2026 showing whole genome sequencing entering routine care
| | |

The OPTIMA Verdict: Two-Thirds of High-Risk Breast Cancer Patients Can Safely Skip Chemotherapy

A landmark phase 3 trial of 4,429 patients showed the Prosigna 50-gene genomic test can safely spare two-thirds of clinically high-risk breast cancer patients from chemotherapy, with equivalent five-year survival…

Senolytic therapy targeting senescent zombie cells in aging tissue during 2026 longevity clinical trials
| |

The Zombie Cell Resistance: Why Senolytic Drugs Keep Failing, and the 2026 Mitochondrial Discovery That Could Change That

A landmark 2026 Nature Aging study reveals why senescent cells resist the drugs designed to kill them: the toughest zombie cells keep their mitochondria pristine. Inside the senolytics reckoning, the…